The efficiency of laser therapy included in the combined treatment of new-onset pulmonary tuberculosis

The present study included 72 patients at the age from 18 to 35 years presenting with new-onset smear-positive pulmonary tuberculosis. They were divided into two groups. Group 1 was comprised of 30 patients treated by infrared laser therapy in the pulsed mode combined with chemotherapy in the II B regimen. Patients of group 2 (n = 42) were treated by chemotherapy alone (in the II B regimen). Patients of the two groups sowed the prevalence of either bilateral processes or unilateral processes affecting at least 1 or 2 lung lobes. One third of the patients carried pathogens refractory to medicamental treatment; in most cases, they displayed polydrug resistance. It was shown that the use of II B chemotherapy in combination with infrared laserotherapy accelerated elimination of intoxication and bronchopulmonary syndromes, resulted in the normalization of hematological characteristics, and arrested microscopically proven bacterioexcretion in all the patients and microbiolgically proven bacterioexcretion in the majority of them. Moreover, this therapeutic strategy allowed polydrug resistance of Mycobacterium tuberculosis to be overcome and efficacy of the closure of the caverns to be improved.

The efficiency of laser therapy included in the combined treatment of newly diagnosed pulmonary tuberculosis, infrared laser therapy, pulmonary tuberculosis, chemotherapy, combined treatment